NEW YORK, Oct. 15-GeneData said today that Wyeth's pharmaceutical research arm would be using its bioinformatics system for functional genomics.
Wyeth will use the Phylosopher system in order to perform comparative genomic analyses of microbial pathogens. The pharmaceutical company will compare the genomes of pharmaceutically interesting pathogens with those from a range of other species in order to identify new targets for anti-infective drugs.
GeneData did not disclose financial details of this licensing agreement.
The Phylosopher bioinformatics system integrates sequence, expression, functional and phenotypic data.
GeneData, a Novartis spinoff, develops functional genomics applications. It is based in Basel, Switzerland.